Literature DB >> 2998062

Anti-complement immunofluorescence establishes nuclear localization of human cytomegalovirus matrix protein.

D Weiner, W Gibson, K L Fields.   

Abstract

A monospecific, polyclonal antiserum to the 69-kDa matrix protein of human cytomegalovirus (HCMV) was prepared in a guinea pig and used to determine the intracellular distribution of this viral antigen. The resulting antiserum was specific for infected cells as tested by immunofluorescence, and specific for the HCMV matrix protein as determined by "nitrocellulose immunoassay" of electrophoretically separated, infected-cell proteins. Antibodies were reacted with fixed, infected human fibroblasts, and visualized by the anti-complement immunofluorescence procedure to avoid complications arising from the strong IgG Fc binding activity of the infected-cell-specific cytoplasmic inclusion. Results establish that the matrix protein is located in the nucleus, and indicate that it is concentrated in the nucleoplasm rather than within the intranuclear inclusions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998062     DOI: 10.1016/0042-6822(85)90223-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication.

Authors:  Veronica Sanchez; Charles L Clark; Judy Y Yen; Roopashree Dwarakanath; Deborah H Spector
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Identification and characterization of a major early cytomegalovirus DNA-binding protein.

Authors:  D G Anders; A Irmiere; W Gibson
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

3.  Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus.

Authors:  C Roby; W Gibson
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

4.  Primate cytomegalovirus glycoproteins: lectin-binding properties and sensitivities to glycosidases.

Authors:  D M Benko; W Gibson
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

5.  Comparative study with monospecific and monoclonal antibodies against a 65 K human cytomegalovirus protein.

Authors:  K Shimokawa; X Bin; T Furukawa
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein.

Authors:  A Gallina; L Simoncini; S Garbelli; E Percivalle; G Pedrali-Noy; K S Lee; R L Erikson; B Plachter; G Gerna; G Milanesi
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  Inhibition by monensin of human cytomegalovirus DNA replication.

Authors:  C J Kaiser; K Radsak
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.